CollabRx, Inc. Schedules Second Quarter Fiscal Year 2014 Financial Conference Call and Business Update

CollabRx, Inc. Schedules Second Quarter Fiscal Year 2014 Financial Conference
Call and Business Update

SAN FRANCISCO, Nov. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX),
a data analytics company focused on genomics, today announced that it will
hold an investor conference call on November 13, 2013 to discuss the Company's
financial results for the second quarter of fiscal 2014 and to provide an
update about the business in the current fiscal year.

The dial-in number for the live audio call beginning on Wednesday, November
13, 2013, at 5 p.m. EST (2 p.m. PST) is (877) 369-6591 in the U.S. and (253)
237-1176 for international participants. The conference identification number
is 88439990. A live webcast of the conference call will also be available at:
http://www.media-server.com/m/p/twc7uik8

A webcast replay of the call will be available for one year and may be
accessed at the same link: http://www.media-server.com/m/p/twc7uik8

About CollabRx

CollabRx, Inc. (Nasdaq:CLRX) is a data analytics company and a leader in
cloud-based expert systems to inform health care decision-making. CollabRx
uses information technology to aggregate and contextualize the world's
knowledge on genomics-based medicine with specific insights from the nation's
top cancer experts starting with the area of greatest need: advanced cancers
in patients who have effectively exhausted the standard of care. More
information may be obtained at http://www.collabrx.com.

CONTACT: CollabRx Contacts:
         Thomas R. Mika, Chairman and CEO
         CollabRx, Inc.
         415-248-5350
        
         James Carbonara, Regional Vice President
         Hayden IR
         646-755-7412
         James@haydenir.com

CollabRx, Inc. Logo
 
Press spacebar to pause and continue. Press esc to stop.